Compare
Utah Medical Products Inc vs Interpace Biosciences, Inc. vs Retractable Technologies Inc vs ClearPoint Neuro, Inc.
| Latest fiscal year | Utah Medical Products Inc UTMD | Interpace Biosciences, Inc. IDXG | Retractable Technologies Inc RVP | ClearPoint Neuro, Inc. CLPT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $38.52M | $38.73M | $38.27M | $36.97M |
| Revenue growth (YoY) | -5.8% | -17.5% | +15.8% | +17.8% |
| Gross margin | 57.1% | 62.3% | 0.1% | 61.4% |
| Operating margin | 29.6% | 10.5% | -55.3% | -65.4% |
| Net margin | 29.3% | 63.5% | -32.8% | -69.1% |
| Net income | $11.29M | $24.57M | -$12.57M | -$25.54M |
| EPS (Diluted) | $3.48 | $0.89 | -$0.43 | -$0.90 |
| Operating cash flow | $14.69M | $5.83M | -$7.06M | -$23.93M |
| Free cash flow | $14.32M | $5.47M | n/a | -$24.45M |
| Cash & equivalents | $85.76M | $2.50M | $2.59M | $45.92M |
| Total assets | $122.54M | $33.84M | $142.63M | $97.75M |
| Total liabilities | $3.27M | $11.47M | $68.26M | $69.73M |
| Shareholders' equity | $119.27M | $22.36M | $74.38M | $28.02M |
| Return on year-end equity | 9.5% | 109.9% | -16.9% | -91.1% |
| Shares outstanding | 3.19M | 4.43M | 29.94M | 29.37M |
Revenue, most recent five fiscal years
| Fiscal year | Utah Medical Products Inc | Interpace Biosciences, Inc. | Retractable Technologies Inc | ClearPoint Neuro, Inc. |
|---|---|---|---|---|
| Latest | $38.52M Ended 2025-12-31 | $38.73M Ended 2025-12-31 | $38.27M Ended 2025-12-31 | $36.97M Ended 2025-12-31 |
| 1 year earlier | $40.90M Ended 2024-12-31 | $46.93M Ended 2024-12-31 | $33.05M Ended 2024-12-31 | $31.39M Ended 2024-12-31 |
| 2 years earlier | $50.22M Ended 2023-12-31 | $40.04M Ended 2023-12-31 | $43.60M Ended 2023-12-31 | $23.95M Ended 2023-12-31 |
| 3 years earlier | $52.28M Ended 2022-12-31 | $31.84M Ended 2022-12-31 | $94.82M Ended 2022-12-31 | $20.55M Ended 2022-12-31 |
| 4 years earlier | $49.05M Ended 2021-12-31 | $33.12M Ended 2021-12-31 | $188.38M Ended 2021-12-31 | $16.30M Ended 2021-12-31 |